95 related articles for article (PubMed ID: 14662021)
1. Expression of pericyte, mesangium and muscle markers in malignant rhabdoid tumor cell lines: differentiation-induction using 5-azacytidine.
Kato H; Ohta S; Koshida S; Narita T; Taga T; Takeuchi Y; Sugita K
Cancer Sci; 2003 Dec; 94(12):1059-65. PubMed ID: 14662021
[TBL] [Abstract][Full Text] [Related]
2. Expression of neural stem cell markers in malignant rhabdoid tumor cell lines.
Okuno K; Ohta S; Kato H; Taga T; Sugita K; Takeuchi Y
Oncol Rep; 2010 Feb; 23(2):485-92. PubMed ID: 20043111
[TBL] [Abstract][Full Text] [Related]
3. Malignant rhabdoid tumor shows incomplete neural characteristics as revealed by expression of SNARE complex.
Yoshida S; Narita T; Taga T; Ohta S; Takeuchi Y
J Neurosci Res; 2002 Sep; 69(5):642-52. PubMed ID: 12210830
[TBL] [Abstract][Full Text] [Related]
4. Malignant rhabdoid tumor shows a unique neural differentiation as distinct from neuroblastoma.
Higashino K; Narita T; Taga T; Ohta S; Takeuchi Y
Cancer Sci; 2003 Jan; 94(1):37-42. PubMed ID: 12708472
[TBL] [Abstract][Full Text] [Related]
5. The autocrine loop of epidermal growth factor receptor-epidermal growth factor / transforming growth factor-alpha in malignant rhabdoid tumor cell lines: heterogeneity of autocrine mechanism in TTC549.
Narita T; Taga T; Sugita K; Nakazawa S; Ohta S
Jpn J Cancer Res; 2001 Mar; 92(3):269-78. PubMed ID: 11267936
[TBL] [Abstract][Full Text] [Related]
6. Malignant rhabdoid-tumor cell line showing neural and smooth-muscle-cell phenotypes.
Sugimoto T; Hosoi H; Horii Y; Ishida H; Mine H; Takahashi K; Abe T; Ohta S; Sawada T
Int J Cancer; 1999 Aug; 82(5):678-86. PubMed ID: 10417765
[TBL] [Abstract][Full Text] [Related]
7. Gene expression of malignant rhabdoid tumor cell lines by reverse transcriptase-polymerase chain reaction.
Suzuki A; Ohta S; Shimada M
Diagn Mol Pathol; 1997 Dec; 6(6):326-32. PubMed ID: 9559292
[TBL] [Abstract][Full Text] [Related]
8. Malignant rhabdoid tumor. A study with two established cell lines.
Ota S; Crabbe DC; Tran TN; Triche TJ; Shimada H
Cancer; 1993 May; 71(9):2862-72. PubMed ID: 8385567
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a cell line from a malignant rhabdoid tumor of the liver lacking the function of two tumor suppressor genes, hSNF5/INI1 and p16.
Kuroda H; Moritake H; Sawada K; Kuwahara Y; Imoto I; Inazawa J; Sugimoto T
Cancer Genet Cytogenet; 2005 Apr; 158(2):172-9. PubMed ID: 15796965
[TBL] [Abstract][Full Text] [Related]
10. Malignant rhabdoid tumors express stem cell factors, which relate to the expression of EZH2 and Id proteins.
Venneti S; Le P; Martinez D; Xie SX; Sullivan LM; Rorke-Adams LB; Pawel B; Judkins AR
Am J Surg Pathol; 2011 Oct; 35(10):1463-72. PubMed ID: 21921784
[TBL] [Abstract][Full Text] [Related]
11. Vascular smooth muscle cells spontaneously adopt a skeletal muscle phenotype: a unique Myf5(-)/MyoD(+) myogenic program.
Graves DC; Yablonka-Reuveni Z
J Histochem Cytochem; 2000 Sep; 48(9):1173-93. PubMed ID: 10950875
[TBL] [Abstract][Full Text] [Related]
12. "Polyphenotypic" tumors in the central nervous system: problems in nosology and classification.
Jay V; Edwards V; Halliday W; Rutka J; Lau R
Pediatr Pathol Lab Med; 1997; 17(3):369-89. PubMed ID: 9185218
[TBL] [Abstract][Full Text] [Related]
13. Pediatric extra-renal rhabdoid tumors with unusual morphology: a diagnostic pitfall for small biopsies.
Alaggio R; Boldrini R; Di Venosa B; Rosolen A; Bisogno G; Magro G
Pathol Res Pract; 2009; 205(7):451-7. PubMed ID: 19243895
[TBL] [Abstract][Full Text] [Related]
14. Trastuzumab activates allogeneic or autologous antibody-dependent cellular cytotoxicity against malignant rhabdoid tumor cells and interleukin-2 augments the cytotoxicity.
Katsumi Y; Kuwahara Y; Tamura S; Kikuchi K; Otabe O; Tsuchiya K; Iehara T; Kuroda H; Hosoi H; Sugimoto T
Clin Cancer Res; 2008 Feb; 14(4):1192-9. PubMed ID: 18281554
[TBL] [Abstract][Full Text] [Related]
15. Chromosome 22q dosage in composite extrarenal rhabdoid tumors: clonal evolution or a phenotypic mimic?
Fuller CE; Pfeifer J; Humphrey P; Bruch LA; Dehner LP; Perry A
Hum Pathol; 2001 Oct; 32(10):1102-8. PubMed ID: 11679945
[TBL] [Abstract][Full Text] [Related]
16. SV40 T antigen inhibits expression of MyoD and myogenin, up-regulates Myf-5, but does not affect early expression of desmin or alpha 7 integrin during muscle development.
Haider SR; Wang W; Kaufman SJ
Exp Cell Res; 1994 Feb; 210(2):278-86. PubMed ID: 7507852
[TBL] [Abstract][Full Text] [Related]
17. Myogenin's functions do not overlap with those of MyoD or Myf-5 during mouse embryogenesis.
Rawls A; Morris JH; Rudnicki M; Braun T; Arnold HH; Klein WH; Olson EN
Dev Biol; 1995 Nov; 172(1):37-50. PubMed ID: 7589813
[TBL] [Abstract][Full Text] [Related]
18. Tissue-Specific Cultured Human Pericytes: Perivascular Cells from Smooth Muscle Tissue Have Restricted Mesodermal Differentiation Ability.
Pierantozzi E; Vezzani B; Badin M; Curina C; Severi FM; Petraglia F; Randazzo D; Rossi D; Sorrentino V
Stem Cells Dev; 2016 May; 25(9):674-86. PubMed ID: 26956507
[TBL] [Abstract][Full Text] [Related]
19. The levels of vascular smooth as well as skeletal muscle actin mRNAs differ substantially among both myoblast and fibroblast lines with different skeletal myogenic potentials.
Sharp SB; Vazquez A; Theimer M; Silva DK; Muscati SR; Sylber M; Mogassa M
Cell Mol Biol (Noisy-le-grand); 1992 Dec; 38(8):903-13. PubMed ID: 1477607
[TBL] [Abstract][Full Text] [Related]
20. The levels of vascular smooth as well as skeletal muscle actin mRNAS differ substantially among both myoblast and fibroblast lines with different skeletal myogenic potentials.
Sharp SB; Vazquez A; Theimer M; Silva DK; Muscati SR; Sylber M; Mogassa M
Cell Mol Biol; 1992 Aug; 38(5):485-504. PubMed ID: 1468109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
